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comorbidities.
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Objectives: We assessed the effects of thoracic endo-
vascular aortic repair (TEVAR) rehearsal with an endovas-
cular surgical simulator in surgical trainees at different
levels in training.
Methods: Twelve trainees in three cohorts (student,
postgraduate year [PGY]1-3, and PGY 4-7) were oriented
to using the Simbionix AngioMentor simulator over four
sessions. Likert scale qualitative analysis evaluated partici-
pant proﬁciency. Analysis of data included one-way analysis
of variance and paired t-tests.
Results: All groups had reduction of total procedure
time (mean 537 6 148 seconds vs 269 6 66 seconds, ﬁrst
session vs fourth; conﬁdence interval [CI], 195-341 seconds;
P < .05) and ﬂuoroscopy time (201 6 74 vs 110 6 37 sec-
onds; CI, 51-132 seconds; P < .05) with case progression.
Procedure time signiﬁcantly decreased in students (551 6
84 vs 313 6 65 seconds; CI 189-287 seconds; P < .05)
and PGY 1-3 (591 6 149 vs 264 6 29 seconds; CI, 113-
541 seconds;P< .02) had a signiﬁcant decrease in procedure
time. Fluoroscopy times were brief overall between individ-
uals and groups and did not change signiﬁcantly with case
progression. Participants acquired proﬁciency after a few
runs in almost every step of the procedure. Endograft sizing
appeared to be the most challenging task by qualitative anal-
ysis. PGY 4-7 trainees had higher technical scores, but this
was not statistically signiﬁcant.
Conclusions: Practice on endovascular surgical simula-
tors can reduce overall procedure and ﬂuoroscopy time,independent of trainee skill level or experience. Endovascu-
lar simulators can be effective tools in residency training and
maintenance of proﬁciency. Further studies are needed to
compare simulator performance with outcomes in real cases.
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Objectives: To evaluate the long-term (up to 24
months) outcome of stenting in TASC A and B and
TASC C and D iliac lesions in a controlled setting.
Methods: The BRAVISSIMO study is a prospective,
nonrandomized, multicenter, multinational, monitored
trial including 325 patients with aortoiliac lesions. The
end point is the primary patency at 24 months, deﬁned
as a target lesion without a hemodynamically signiﬁcant
stenosis on duplex ultrasound imaging (>50%, systolic ve-
locity ratio >2.0). A separate analysis for TASC A and B vs
TASC C and D population is performed.
Results: Between July 2009 and September 2010,
190 patients with TASC A or B and 135 patients with
TASC C or D aortoiliac lesions were included. The demo-
graphic data were comparable for the TASC A/B cohort
and the TASC C/D cohort. Technical success was 100%.
Signiﬁcantly more balloon-expandable stents were
deployed in TASC A and B lesions, and considerably
more self-expanding stents were placed in TASC C and
